In more detail, it could be demonstrated that preventive systemic delivery of stabilized CcnE1-siRNA in vivo only once a week was sufficient to inhibit Cyclin E1 induction in settings of both, acute and chronic liver injury, and this was sufficient to prevent the initiation of experimental liver fibrosis. This evidence concerns the gene CCNE1 and Hepatic fibrosis.